Should We Be Concerned About Hantavirus? What Experts Want You to Know
A virus that has circulated silently in wild rodent populations for decades just made an unprecedented appearance. It did so aboard a luxury cruise ship traversing the Atlantic Ocean. Between early April and mid-May 2026, the MV Hondius became the site of the first documented hantavirus outbreak to occur on a vessel. It infected passengers and crew with the Andes strain of a rare but deadly pathogen.
The World Health Organization confirmed 11 cases, including three deaths. American passengers are quarantined in Nebraska. Australians, Europeans, and citizens from at least 23 countries have scattered to their home nations, all of them potentially exposed. Contact tracers are working what the United Kingdom Health Security Agency describes as “a mammoth effort.” They are trying to locate passengers who disembarked early at remote islands and tracking their movements through airports and flights across the globe.
The situation has prompted comparisons to COVID-19, raising questions about the potential for a pandemic. And left people wondering: Should we be worried?
The answer, according to epidemiologists and infectious disease specialists, is no. However, understanding why requires knowing what hantavirus actually is. It also implies understanding how the Andes strain differs from other viruses. And why this outbreak, while unusual, does not signal the beginning of a pandemic.
The outbreak
In early April 2026, the MV Hondius departed from Ushuaia, Argentina, carrying nearly 150 passengers and crew members. The ship was bound for remote wildlife areas, including stops in Antarctica and the South Atlantic islands of Tristan da Cunha and St. Helena.
By mid-April, someone aboard had fallen critically ill. The passenger died, according to the cruise operator Oceanwide Expeditions, of unknown causes at the time. On April 24, about 30 passengers disembarked in St. Helena, before the outbreak was identified. One of them was the wife of the deceased passenger. She flew to Johannesburg, South Africa, where she died on April 26.
It was not until early May that additional crew members and passengers began showing severe respiratory symptoms. Testing revealed the culprit was the hantavirus, specifically the Andes strain. By May 4, the WHO had confirmed an outbreak. By May 12, the death toll had reached three.
What made this outbreak unprecedented was not the virus itself, but its location. Hantavirus had never been documented on a cruise ship before. Scientists have known about the pathogen since the 1980s, when it killed people in the American Southwest. But a trans-Atlantic passenger vessel in 2026 represented a first.
What the Andes strain can do
Hantavirus is not one virus but a group of zoonotic pathogens. Meaning, they originate in animals and can cause disease in humans. According to the CDC, at least 20 strains are known to cause disease in humans. Most circulate in wild rodents—particularly mice and rats—without causing the animals any apparent illness.
The Andes strain, found primarily in South America, is what Dr. Kari Moore Debbink, a professor of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health, calls “the unusual one.” It is the only hantavirus strain documented to spread from person to person.
Most hantavirus infections occur when people inhale microscopic particles from infected rodent urine, feces, or saliva. This typically happens when cleaning out a remote cabin or workspace infested with wild rodents. The CDC has logged 890 cases of hantavirus disease in humans since surveillance began in 1993, with 94 percent occurring west of the Mississippi River, primarily in Colorado, Arizona, and New Mexico.
Its impact can be severe.
The Andes strain causes hantavirus pulmonary syndrome, a disease that begins with flu-like symptoms: fever, chills, fatigue, muscle aches, and sometimes gastrointestinal distress. Within four to ten days, symptoms can rapidly progress to severe pneumonia, fluid in the lungs, coughing fits, and respiratory failure.
“The fatality rate of hantavirus pulmonary syndrome is 30 to 40 percent,” says Debbink. There is no vaccine, nor is there specific antiviral therapy. Doctors can offer only supportive care: supplemental oxygen, mechanical ventilation, or, in the most severe cases, extracorporeal membrane oxygenation, a machine that takes over the work of the heart and lungs while the body fights the infection.
The incubation period—the time between exposure and symptom onset—ranges from one to eight weeks. That timeframe means authorities cannot yet know the full scope of the outbreak. Any of the 30 passengers who left the ship early in St. Helena could develop symptoms in the coming weeks. The same applies to the remaining passengers, crew, and airport workers, flight attendants, and others who came into contact with potentially infected people during evacuation flights.
How hantavirus spreads between people
The Andes strain is unique in its ability to transmit between humans, but the word “ability” should not be mistaken for ease of transmission.
“There are respiratory viruses like flu and COVID-19 that are incredibly efficient at transmitting person to person,” Debbink says. “Hantavirus just isn’t like that.”
Unlike COVID-19, which replicates in the upper respiratory tract at high levels and spreads easily through coughing and sneezing, hantavirus burrows deep into the lungs and infects blood vessels. The virus sheds less readily from the respiratory tract. It lacks the evolutionary adaptations that make influenza or COVID-19 such efficient transmitters.
“It’s not very easy for the virus to get out,” according to Bryce Warner, a research scientist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan who has extensively researched hantavirus.
Data from previous Andes strain outbreaks show that transmission between people requires close, prolonged contact with someone who is already showing symptoms of infection. In 2018, when the Andes strain infected 34 people in Patagonia, Argentina, causing 11 deaths, the outbreak began when one infected person attended a birthday party of approximately 100 people. Over the following months, just three symptomatic individuals—attending other social gatherings while ill—drove all 34 infections.
“More than 80 health care workers who had unprotected contact with patients were not infected,” according to analysis of that outbreak, underscoring how inefficiently the virus tends to jump between humans even in clinical settings.
On the cruise ship, investigators believe some transmissions may have occurred among passengers who shared cabins and dining areas. According to the WHO, Dr. Maria Van Kerkhove said some cases involved “close contact with one another, and human-to-human transmission can’t be ruled out.” But how exactly each person became infected remains under investigation.
The risk remains low
All public health officials—from the WHO to the CDC to Stanford Medicine—have emphasized the same point: the risk to the general public is extremely low.
The American passengers who arrived in the United States on May 11 included one individual who tested “mildly PCR-positive” for hantavirus and was sent to a specialized bio-containment facility in Omaha, Nebraska. Another passenger showed mild symptoms but tested negative for hantavirus. The remaining 16 Americans were taken to the National Quarantine Unit in Omaha.
All passengers who disembarked from the ship on May 10 wore extensive personal protective equipment and left in isolated groups, according to Boris Pavlin, a WHO medical epidemiologist. Contact tracing is underway globally, with health authorities locating and monitoring everyone who may have been exposed to confirmed cases.
“We are prepared for situations exactly like this. Our teams have trained for decades,” said Dr. Michael Ash, CEO of Nebraska Medicine, which is housing the American quarantined passengers.
Dr. Tedros Adhanom Ghebreyesus, director-general of the WHO, told reporters on May 12 that authorities have located the passengers who disembarked early. “As far as we know, the passengers who disembarked have all been located,” he said.
The risk to the general public—people who were not on the ship, did not work in its medical facilities, and did not travel on the same flights—is negligible, epidemiologists say. “Your risk of acquiring this particular rare infection on a plane or ship is very, very low,” said Jorge Salinas, medical director of infection prevention at Stanford Health Care. “If you asked me last month, I wouldn’t have predicted that we would see this on a cruise ship. I would still say that your risk is very, very low.”
Why Hantavirus is not COVID-19
When news of a deadly virus outbreak on a ship broke in early May, comparisons to COVID-19 were immediate and inevitable. Both involved cruise ships, prompting evacuations and quarantines. Both raised fears of a global virus outbreak.
The similarities end there.
COVID-19 became a pandemic because SARS-CoV-2 spreads with extraordinary efficiency between humans. The virus replicates to high levels in the upper respiratory tract. It disperses easily through respiratory droplets from asymptomatic or minimally symptomatic people. The virus was, so to speak, designed by evolution to transmit between humans at scale.
Hantavirus, even the Andes strain, was not. It evolved in rodents. Its occasional transmission to humans was incidental to its evolutionary history. When it does transmit between people, it does so rarely, in specific circumstances involving close contact with someone who is symptomatic.
“This is not COVID,” Pavlin told NBC News. “In COVID, we’ve all been traumatized by how people you didn’t even think were sick were already spreading it. We have no reason to believe that that’s happening here.”
Dr. Emily Abdoler, a clinical associate professor of infectious diseases at Michigan Medicine, emphasized that past cases of hantavirus spreading between humans had not resulted in large outbreaks. “Nothing even close to the scale of COVID,” she said.
There is no evidence that the Andes virus has mutated into a more transmissible variant. There is no reason to expect an exponential spread. The outbreak is contained to people with direct or close contact exposure to confirmed cases.
What a weeks-long incubation implies
The challenge facing health authorities is not the speed at which the virus spreads, but the length of time it takes to manifest.
With an incubation period of one to eight weeks, a person exposed to the Andes strain on May 4 might not develop symptoms until mid-June. That timeline creates a shadow period during which infected individuals can travel, return home, and resume their lives, inadvertently exposing others before realizing they are ill.
This is why the British passengers who returned to the United Kingdom are isolating for 72 hours in a hospital, then for an additional 42 days at home. It is also why the 30 passengers who disembarked in St. Helena before the outbreak was identified are being monitored across at least 12 countries.
More people may show symptoms in the coming weeks. Some may have been exposed on the ship. Others may have been exposed during evacuation flights or at airports. Some may have exposed others before their own symptoms appeared.
But the fact that someone develops symptoms does not necessarily mean the virus will spread further. It means that the person will isolate, receive supportive medical care, and allow their immune system to fight an infection that science still does not fully understand.
“Because this virus is so rare, there just hasn’t been a whole lot of research into it,” Salinas said. Data is sparse on whether certain groups—young children, elderly adults, immunocompromised people—are more likely to become severely ill. Researchers do not know if some people shed more virus than others or transmit more readily. The rarity of hantavirus has made it a low research priority, leaving clinicians with limited treatment options during outbreaks.
What specialists are expecting in the next few weeks
The MV Hondius outbreak is not the first time a zoonotic virus—one that jumped from animals to humans—has created a public health crisis. Hantavirus, Ebola, avian influenza, and COVID-19 all share that origin story. According to the CDC, about three-quarters of all emerging infectious diseases are zoonotic, and scientists expect that proportion to increase as humans push deeper into wildlife habitats and as climate change reshapes where animals live and breed.
“Given the way the world keeps changing and our populations are growing and moving, viruses will keep leaping from animals to humans,” Salinas said. “I expect this hantavirus outbreak to end, but it won’t be the last, and it’s a reminder that outbreaks can occur in unpredictable locations.”
The current outbreak appears to have begun when at least one passenger came into contact with an infected rodent in Argentina before boarding the ship. How that initial exposure occurred—whether through staying in a cabin, hiking, or another activity—remains under investigation.
Health authorities will continue monitoring passengers and crew.
They will trace contacts. They will watch for symptom development. And when symptoms emerge, they will provide supportive care and isolate the patient to prevent further spread.
In the meantime, the average person should not change their behavior. Cruise ships are not hantavirus vectors. Airports are not hantavirus reservoirs. The virus remains what it has always been: a rare pathogen of wild rodents that occasionally infects humans under specific circumstances.
For people in the Western United States working in close proximity to wild rodents—cleaning out cabins, sheds, or agricultural spaces—basic precautions make sense. Wearing gloves, using a bleach solution to wet surfaces before cleaning, avoiding sweeps or vacuuming that might aerosolize particles, and wearing a well-fitting N95 mask can reduce exposure risk. The same precautions guard against other diseases as well.
For everyone else, the answer to whether we should be concerned about hantavirus is simple: No. But it is worth remembering that the virus exists, that outbreaks can happen in unexpected places, and that our ability to respond depends on swift coordination, clear communication, and the willingness to invest in research for diseases that are rare until, suddenly, they are not.



